These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17898884)

  • 21. Molecular mechanisms of action of anti-TNF-α agents - Comparison among therapeutic TNF-α antagonists.
    Mitoma H; Horiuchi T; Tsukamoto H; Ueda N
    Cytokine; 2018 Jan; 101():56-63. PubMed ID: 27567553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.
    Choudhury R; Das P; De T; Chakraborti T
    Immunobiology; 2013 Jan; 218(1):114-26. PubMed ID: 22440312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists.
    Curtis JR; Patkar N; Xie A; Martin C; Allison JJ; Saag M; Shatin D; Saag KG
    Arthritis Rheum; 2007 Apr; 56(4):1125-33. PubMed ID: 17393394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role and effect of TNF-alpha in experimental visceral leishmaniasis.
    Tumang MC; Keogh C; Moldawer LL; Helfgott DC; Teitelbaum R; Hariprashad J; Murray HW
    J Immunol; 1994 Jul; 153(2):768-75. PubMed ID: 8021511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pseudolymphomatoid cutaneous leishmaniasis in a patient treated with adalimumab for rheumatoid arthritis.
    Baltà-Cruz S; Alsina-Glbert M; Mozos-Rocafort A; Cervera C; Colomo-Saperas L; Del Río A; Estrach-Panella T
    Acta Derm Venereol; 2009; 89(4):432-3. PubMed ID: 19688168
    [No Abstract]   [Full Text] [Related]  

  • 26. Adalimumab for rheumatoid arthritis.
    Voulgari PV; Drosos AA
    Expert Opin Biol Ther; 2006 Dec; 6(12):1349-60. PubMed ID: 17223742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.
    Bongartz T; Sutton AJ; Sweeting MJ; Buchan I; Matteson EL; Montori V
    JAMA; 2006 May; 295(19):2275-85. PubMed ID: 16705109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study.
    Weisman MH; Moreland LW; Furst DE; Weinblatt ME; Keystone EC; Paulus HE; Teoh LS; Velagapudi RB; Noertersheuser PA; Granneman GR; Fischkoff SA; Chartash EK
    Clin Ther; 2003 Jun; 25(6):1700-21. PubMed ID: 12860493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
    Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A
    Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial.
    Keystone EC; Kavanaugh AF; Sharp JT; Tannenbaum H; Hua Y; Teoh LS; Fischkoff SA; Chartash EK
    Arthritis Rheum; 2004 May; 50(5):1400-11. PubMed ID: 15146409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visceral leishmaniasis in a patient with rheumatoid arthritis treated with methotrexate.
    Loarce-Martos J; Garrote-Corral S; Gioia F; Bachiller-Corral J
    Reumatol Clin (Engl Ed); 2019; 15(6):e130-e132. PubMed ID: 28958842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cutaneous infection due to Mycobacterium chelonae during anti-TNF therapy].
    Adenis-Lamarre E; Kostrzewa E; Texier-Maugein J; Doutre MS
    Ann Dermatol Venereol; 2009 Nov; 136(11):811-4. PubMed ID: 19917435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Interpretation of laboratory data during cryptic leishmaniasis in dog].
    Gravino AE
    Parassitologia; 2004 Jun; 46(1-2):227-9. PubMed ID: 15305723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of type 1 diabetes mellitus in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor alpha.
    Richez C; Blanco P; Gin H; Schaeverbeke T
    Clin Exp Rheumatol; 2006; 24(5):607. PubMed ID: 17181936
    [No Abstract]   [Full Text] [Related]  

  • 35. Combined neutralization of interferon gamma and tumor necrosis factor alpha induces IL-4 production but has no direct additive impact on parasite burden in splenic cultures of human visceral leishmaniasis.
    Singh N; Sundar S
    PLoS One; 2018; 13(6):e0199817. PubMed ID: 29953494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visceral leishmaniasis in a psoriatic arthritis patient treated with methotrexate.
    Hadjipetrou A; Anyfantakis D; Gkogkou A; Palla K; Lagoudaki E; Milonaki T; Kastanakis S
    Infez Med; 2014 Sep; 22(3):230-5. PubMed ID: 25269966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?
    Askling J; van Vollenhoven RF; Granath F; Raaschou P; Fored CM; Baecklund E; Dackhammar C; Feltelius N; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Rantapää-Dahlqvist S; Saxne T; Klareskog L
    Arthritis Rheum; 2009 Nov; 60(11):3180-9. PubMed ID: 19877027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of anti-tumor necrosis factor therapy (Adalimumab) on regulatory T cells and dendritic cells in rheumatoid arthritis.
    Dombrecht EJ; Aerts NE; Schuerwegh AJ; Hagendorens MM; Ebo DG; Van Offel JF; Bridts CH; Stevens WJ; De Clerck LS
    Clin Exp Rheumatol; 2006; 24(1):31-7. PubMed ID: 16539816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis.
    Capsoni F; Sarzi-Puttini P; Atzeni F; Minonzio F; Bonara P; Doria A; Carrabba M
    Arthritis Res Ther; 2005; 7(2):R250-5. PubMed ID: 15743471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cutaneous leishmaniasis in rheumatoid arthritis].
    Hachicha I; Sellami M; Fourati H; Akrout R; Hdiji N; Baklouti S
    Rev Med Interne; 2009 Jul; 30(7):609-12. PubMed ID: 19285366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.